Today's Daily Dose brings you news about FDA approval of TherapeuticsMD's BIJUVA; CTD Holdings' patent filing related to methods for treating Alzheimer's disease; Amedisys' third-quarter results and rosy outlook for the year, and Genmab's phase III multiple myeloma study.
from RTT - Biotech https://ift.tt/2EUipvR
via IFTTT
No comments:
Post a Comment